Drugs / X vivo gene therapy
last change Oct 2025 re-read 3 minutes ago

X vivo gene therapy

Developed for
granulomatous disease, chronic, X-linked
Investigated by
Genethon

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02757911 Jun 2013 → Sep 2019 granulomatous disease, chronic, X-linked Genethon Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as X vivo gene therapy ClinicalTrials.gov intervention name — accepted as the source's own label NCT02757911 ↗